Tweet
Comerica Bank reduced its position in shares of Chemed Co. (NYSE:CHE) by 25.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,598 shares of the company's stock after selling 4,406 shares during the period. Comerica Bank owned 0.08% of Chemed worth $4,106,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Hartford Investment Management Co. acquired a new stake in Chemed during the second quarter worth about $243,000. Zeke Capital Advisors LLC acquired a new stake in Chemed during the first quarter worth about $218,000. Grimes & Company Inc. acquired a new stake in Chemed during the first quarter worth about $218,000. We Are One Seven LLC increased its position in Chemed by 234.0% during the first quarter. We Are One Seven LLC now owns 805 shares of the company's stock worth $220,000 after purchasing an additional 564 shares during the last quarter. Finally, LPL Financial LLC acquired a new stake in Chemed during the first quarter worth about $236,000. Hedge funds and other institutional investors own 95.06% of the company's stock. Get Chemed alerts:
In other Chemed news, Director Patrick P. Grace sold 250 shares of Chemed stock in a transaction dated Friday, June 22nd. The shares were sold at an average price of $323.76, for a total transaction of $80,940.00. Following the completion of the sale, the director now directly owns 4,520 shares in the company, valued at $1,463,395.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, insider Kevin J. Mcnamara sold 19,000 shares of Chemed stock in a transaction dated Tuesday, June 19th. The shares were sold at an average price of $322.27, for a total transaction of $6,123,130.00. Following the sale, the insider now owns 124,491 shares of the company's stock, valued at $40,119,714.57. The disclosure for this sale can be found here . Over the last quarter, insiders have sold 19,450 shares of company stock valued at $6,269,496. Company insiders own 4.82% of the company's stock.
CHE has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Chemed from a "hold" rating to a "buy" rating and set a $350.00 price objective for the company in a research report on Tuesday, July 31st. ValuEngine upgraded shares of Chemed from a "buy" rating to a "strong-buy" rating in a research report on Friday, May 4th. Finally, Royal Bank of Canada raised their price objective on shares of Chemed to $321.00 and gave the stock a "market perform" rating in a research report on Monday, July 30th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Chemed presently has a consensus rating of "Buy" and an average price target of $315.33.
Shares of CHE opened at $316.95 on Friday. Chemed Co. has a 1-year low of $186.09 and a 1-year high of $335.99. The stock has a market cap of $5.08 billion, a price-to-earnings ratio of 59.13, a P/E/G ratio of 2.86 and a beta of 1.16. The company has a quick ratio of 1.01, a current ratio of 1.04 and a debt-to-equity ratio of 0.19.
Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, July 25th. The company reported $2.81 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.04. Chemed had a net margin of 11.00% and a return on equity of 33.57%. The business had revenue of $441.80 million during the quarter, compared to analysts' expectations of $434.28 million. During the same period last year, the business earned $2.15 earnings per share. The business's revenue for the quarter was up 6.4% on a year-over-year basis. equities research analysts predict that Chemed Co. will post 11.05 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, August 31st. Shareholders of record on Monday, August 13th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 10th. This is a boost from Chemed's previous quarterly dividend of $0.28. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.38%. Chemed's dividend payout ratio (DPR) is currently 22.39%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Featured Story: What are Closed-End Mutual Funds?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE). Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter 